Lionsgate: Will Continue To Roar

Lionsgate Studios (LION) offers a premier, recently produced content library, making it a unique acquisition target post-WBD deal. LION trades at less than 10x TTM library EBITDA, with a 12x multiple implying over $13/share value and free upside from production assets. Strategic stakes by Liberty Strategic Capital and MHR, plus a poison pill, signal heightened acquisition interest and potential for a bidding war.